Employees: 1001-5000
Founded date: 1947
Mentions in press and media 11
Date | Title | Description |
29.08.2024 | Provided PROTEAN Career Dock, a program for proactively carving out a career, to Ono Pharmaceutical Co., Ltd. | Provided PROTEAN Career Dock, a program for proactively carving out a career, to Ono Pharmaceutical Co., Ltd. *PROTEAN CAREER ASSOCIATION* Press release: August 30, 2024 ** Provided PROTEAN Career Dock, a program for proactively carving out... |
31.07.2024 | Ono Pharmaceutical Co., Ltd. introduces “HiTalent” business professional utilization service centered on experienced strategic consultants | Ono Pharmaceutical Co., Ltd. introduces “HiTalent” business professional utilization service centered on experienced strategic consultants *High Talent Co., Ltd.* Press release: July 31, 2024 ** Ono Pharmaceutical Co., Ltd. introduces “HiTa... |
27.06.2024 | ONO PHARMA USA's Generous Support for Conquer Cancer's Mission | ONO PHARMA USA, a leading pharmaceutical company, has announced a significant sponsorship of $1 million to support Conquer Cancer, the ASCO Foundation. This partnership aims to advance cancer research and education, with a focus on accelera... |
25.06.2024 | ONO PHARMA USA Announces Support for Conquer Cancer®, the ASCO Foundation | Conquer Cancer Supports Cancer Research and Education CAMBRIDGE, Mass., June 25, 2024 /PRNewswire/ -- ONO PHARMA USA today announced it will provide a sponsorship to Conquer Cancer®, the ASCO Foundation, with $1 million funding to advance c... |
25.06.2024 | ONO PHARMA USA Announces Support for Conquer Cancer®, the ASCO Foundation | Conquer Cancer Supports Cancer Research and Education CAMBRIDGE, Mass., June 25, 2024 /PRNewswire/ -- ONO PHARMA USA today announced it will provide a sponsorship to Conquer Cancer®, the ASCO Foundation, with $1 million funding to advance c... |
25.04.2024 | PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono | PRISM BioLab will utilize PepMetics®, innovative small molecules that mimic three-dimensional structures of alpha-helix and beta-turns of peptides for drug discovery against oncology target selected by Ono TOKYO, April 25, 2024 /PRNewswire/... |
18.01.2024 | Tech Doctor Co., Ltd. Japan Digital Health Alliance formulates guidelines for the use of generative AI specialized in the healthcare field | [Tech Doctor Co., Ltd.] Japan Digital Health Alliance formulates guidelines for the use of generative AI specialized in the healthcare field *View in browser* *Tech Doctor Co., Ltd.* Press release: January 18, 2024 ** Japan Digital Health A... |
18.01.2024 | Japan Research Institute, Ltd. Establishment of guidelines for the use of generative AI specialized in the healthcare field ~ Creating a foundation that allows consumers to use generative AI services ... | [Japan Research Institute, Ltd.] Establishment of guidelines for the use of generative AI specialized in the healthcare field ~ Creating a foundation that allows consumers to use generative AI services with peace of mind ~ *View in browser*... |
07.02.2022 | Ono Pharmaceutical : Corporate Governance Report | Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. Corporate Governance Rep... |
12.08.2021 | Healx launches AI-powered indication expansion partnership with Ono Pharmaceutical | Healx launches AI-powered indication expansion partnership with Ono Pharmaceutical 12-08-2021 Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, today announced an exciting partnersh... |
Show more